Search Results for 'cancer ovarian'

cancer ovarian published presentations and documents on DocSlides.

British Gynaecological Cancer Society

British Gynaecological Cancer Society

by obrien

1 BGCS ) Epithelial Ovarian / Fallopian Tube / ...

There are 31ve main types of cancer that a30ect a woman146s

There are 31ve main types of cancer that a30ect a woman146s

by luna

reproductive organs: cervical, ovarian, uterine, v...

Fertility Preservation in Breast Cancer

Fertility Preservation in Breast Cancer

by mia

Dr s.Hosseini. SBMU. Summer 2019. INTRODUCTION. Br...

MD Anderson Cancer Center

MD Anderson Cancer Center

by allen

MDACC Clinical . Validation Center . for. Early . ...

by liane-varnes

Annual Ob-Gyn Update. Ovarian Cancer:. Finally. ...

Lynch Syndrome and BRCA 1/2

Lynch Syndrome and BRCA 1/2

by yoshiko-marsland

21 yo female px to GP with 3/52 of severe abdomin...

All Our Ovaries

All Our Ovaries

by stefany-barnette

Ovarian Health Bulletin Board. Submitted by Abby ...

* But I’m Too

by cheryl-pisano

Young!. A. Case Study of Ovarian Cancer. by. Nan...

28 Million £ Down The Drain

28 Million £ Down The Drain

by briana-ranney

Muhieddine Seoud, MD, FACOG, FACS. American Unive...

Emergency Presentations in Gynaecological Oncology

Emergency Presentations in Gynaecological Oncology

by calandra-battersby

Rob . Gornall. Gynaecological Oncology. Urgent pr...

Transforming treatment and improving survival for

Transforming treatment and improving survival for

by olivia-moreira

ovarian cancer patients. Laura Shawver, PhD. Foun...

Michelle Boisen , MD Assistant professor of Gynecologic oncology

Michelle Boisen , MD Assistant professor of Gynecologic oncology

by calandra-battersby

Magee-. Womens. Hospital of UPMC. Clinical and R...

Elizabeth Kent MD Medical Oncology/Hematology

Elizabeth Kent MD Medical Oncology/Hematology

by test

May 19, 2017. Hereditary Cancer Syndromes. Recogn...

State of the Art in BRCA

State of the Art in BRCA

by ellena-manuel

-Mutated Ovarian Cancer. This program will includ...

Endometriosis & Cancer Association

Endometriosis & Cancer Association

by kittie-lecroy

Paul Yong, MD, PhD, FRCSC. Gynaecologist. , VGH/U...

Precision Medicine in the management of gynecologic cancers

Precision Medicine in the management of gynecologic cancers

by stefany-barnette

Randal West, MD. Ovarian cancer standard of care....

به نام خداوند بخشنده و مهربان

به نام خداوند بخشنده و مهربان

by faustina-dinatale

Adnexal Mass. Observation vs Intervention. M.Mohi...

1 Evaluation of an

1 Evaluation of an

by aaron

1 Evaluation of an Adnexal Mass Reviewed by Bil...

Patient Selection for PARP

Patient Selection for PARP

by sherrill-nordquist

Inhibitors:. Purpose and Practicalities . Present...

De asymptomatische screenings

De asymptomatische screenings

by asmurgas

patiënte. . Kan . het zonder echografie?. Dirk Ti...

Behandeling van het recidief ovariumcarcinoom

Behandeling van het recidief ovariumcarcinoom

by sandsomber

Ignace Vergote MD PhD FACS FSPS. Chairman, Leuven ...

by medshair

Five-year . survival. 15%. 30%. 40%. ?50%?. First ...

by eddey

Ca Doct Y Y Y Y Y Y Pati Rev 4/201 Y ...

some recent data and ideas

some recent data and ideas

by ariel

Rare tumoursPart two endometriosis associated canc...

Hereditary syndromes, genetic testing and

Hereditary syndromes, genetic testing and

by Kingslayer

gynaecological. cancers. Prof.. Nicoletta . Col...

DISORDERSETTING

DISORDERSETTING

by rose

Question 1: What is the specific clinical disorder...

depends on stage histological type age presence of ascitesin patie

depends on stage histological type age presence of ascitesin patie

by skylar

SUSANNE MARKMANN, BERND GERBER andVOLKER BRIESE Ne...

e110 VOL 130 NO 3 SEPTEMBER 2017 OBSTETRICS GYNECOLOGY

e110 VOL 130 NO 3 SEPTEMBER 2017 OBSTETRICS GYNECOLOGY

by finley

tiple family members with breast cancer, ovarian c...

by caitlin

Kunle Immunotherapy in Ovarian Cancer Kunle Oduns...

Clare Churcher Senior Lecturer in USW

Clare Churcher Senior Lecturer in USW

by linda

Ovarian Cancer – The Silent Killer . Silent kill...

What Clinicians Want to Know:

What Clinicians Want to Know:

by violet

Understanding the Factors Affecting the Optimal Di...

Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i

Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i

by zen

knowledge. ). Incorporate evidence-based research ...

NW regional audit of CA125 requesting in primary care

NW regional audit of CA125 requesting in primary care

by atharv578

NW Audit meeting format. Start of collaborative NW...

A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD.

A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD.

by sherrill-nordquist

A few thoughts on cancer and cancer family syndro...

IntroductionBreast cancer is the most common cancer among women worldw

IntroductionBreast cancer is the most common cancer among women worldw

by tracy

, Seda Klç , Demet Akdeniz , Özge &#17...

Hormonal Regulation of Male Reproductive Function

Hormonal Regulation of Male Reproductive Function

by conchita-marotz

Sequence of hormonal regulatory events involving ...

by calandra-battersby

– . 30, 2015. , Montréal, Québec. Female Pelv...

Case Discussion: Second

Case Discussion: Second

by celsa-spraggs

Opinion. 55 year-old woman with . recurrent . ova...

Pelvic Mass in the Female Patient

Pelvic Mass in the Female Patient

by karlyn-bohler

Differentials and Workup. David C Murphy, D.O.. I...

Approach to the patient with an adnexal mass

Approach to the patient with an adnexal mass

by trish-goza

Dr. . Safoura. . Rouholamin. Isfahan Medical Un...